Sponsored by:

Nuclear Medicine: Page 194

Nordion discloses internal probe
By AuntMinnie.com staff writers
Nordion is conducting an internal investigation of a foreign supplier and related parties regarding compliance with the Canadian Corruption of Foreign Public Officials Act and the U.S. Foreign Corrupt Practices Act.
August 8, 2012
ImaginAb inks Singapore service agreement
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb has signed a master service agreement with Singapore Radiopharmaceuticals, a subsidiary of Fortis Healthcare.
August 7, 2012
Positron consolidates facilities
By AuntMinnie.com staff writers
PET developer Positron has announced the consolidation and integration of operations at its Crown Point, IN, facility into its Lubbock, TX, site.
August 7, 2012
IBA, Piramal ink deal on F-18 amyloid imaging
By AuntMinnie.com staff writers
Radiopharmaceutical provider IBA Molecular and Piramal Imaging have announced an agreement under which IBA will manufacture and distribute F-18 florbetaben, Piramal's new diagnostic imaging agent, in the European and U.S. markets.
August 6, 2012
Work-in-progress PET/MRI breast scanner finds tiny lesions
By Wayne Forrest
While there is still much work ahead, breast MRI developer Aurora Imaging Technology and the Brookhaven National Laboratory say preliminary results from a work-in-progress PET/MRI breast scanner are promising, with the system detecting breast lesions smaller than 5 mm.
August 6, 2012
2012 08 07 09 15 00 482 Aurora Pet Mri Image Thumb
Alzheimer's disease: Reason for hope
By Dr. Gregory Sorensen
When President Reagan welcomed women's basketball coach Pat Summitt to the White House 25 years ago, no one knew that Alzheimer's would someday become a thread connecting them. Fortunately, imaging now offers more certainty for those who may unknowingly have the disease, according to Siemens Healthcare CEO Dr. Gregory Sorensen.
August 5, 2012
2012 08 03 13 29 17 498 Sorensen Gregory 70
Molecular Targeting licenses agent from MCW
By AuntMinnie.com staff writers
Biotechnology developer Molecular Targeting Technologies has received an exclusive license from the Medical College of Wisconsin (MCW) for rights to a U.S. patent covering a technetium-99m radiopharmaceutical for noninvasive imaging of dead and dying cells.
August 1, 2012
SPECT/CT aids in tough endocarditis cases
By AuntMinnie.com staff writers
The combination of SPECT/CT and white blood cells labeled with a technetium-99m radiopharmaceutical can improve the diagnosis of infectious endocarditis in difficult cases, according to a new study in the August issue of the Journal of Nuclear Medicine.
July 31, 2012
Navidea licenses Parkinson's imaging agent
By AuntMinnie.com staff writers
Navidea Biopharmaceuticals has signed an agreement with Alseres Pharmaceuticals to license its iodine-123 radiolabeled agent, which is being developed to help diagnose Parkinson's disease and other movement disorders, with a potential use as a diagnostic aid in dementia.
July 31, 2012
MITA offers educational kits for PET
By AuntMinnie.com staff writers
The Medical Imaging and Technology Alliance (MITA) has released its Demonstrating Excellence Through Advanced Imaging Learning (DETAIL) program, which provides resources for physicians and patients to learn about PET scans.
July 30, 2012
Naviscan brings PEM to Japan
By AuntMinnie.com staff writers
PET developer Naviscan has received Shonin approval from the Japanese Ministry of Health, Labor, and Welfare to market its high-resolution PET technology, including its positron emission mammography (PEM) breast application.
July 30, 2012
Imaging of terminally ill rises; PEM for arthritis; history of radiation oncology
By Brian Casey
July 30, 2012
Previous Page
Page 194 of 440
Next Page